These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 285569)

  • 41. Asymptomatic Bartter's syndrome.
    Barbour GL; Day JO
    South Med J; 1978 Nov; 71(11):1341-4, 1349. PubMed ID: 715482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correction of increased prostacyclin synthesis in Bartter's syndrome by indomethacin treatment.
    Gullner HG; Smith JB; Cerletti C; Gill JR; Bartter FC
    Prostaglandins Med; 1980 Feb; 4(2):65-72. PubMed ID: 6994153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Escape from sodium and potassium retaining actions of aspirin-like drugs used in a patient with Bartter's syndrome.
    Ishikawa Y; Wada T
    Jpn Circ J; 1979 Aug; 43(8):757-67. PubMed ID: 501898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors.
    Littlewood JM; Lee MR; Meadow SR
    Arch Dis Child; 1978 Jan; 53(1):43-8. PubMed ID: 415668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A fortultousness association: Bartter's syndrome and chondrocalcinosis (author's transl)].
    Goulon M; Raphael JC; De Rohan P
    Nouv Presse Med; 1980 Apr; 9(18):1291-5. PubMed ID: 7375363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bartter's syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin.
    Rodriguez-Soriano J; Vallo A; Oliveros R
    Helv Paediatr Acta; 1978 Jun; 33(2):141-51. PubMed ID: 659258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome.
    Vierhapper H; Waldhäusl W
    Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):119-24. PubMed ID: 6780358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of factors influencing the renin-aldosterone system in a patient with Bartter's syndrome.
    Sudan M; Stacy WK; Falls WF
    South Med J; 1979 Jul; 72(7):779-82. PubMed ID: 451681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Bartter's syndrome. Failure of aspirin and success of indomethacin].
    Jáuregui WO; Di Fonzo P; Marchissio ML; Roehr E; Hauger-Klevene JH
    Medicina (B Aires); 1979; 39(4):447-56. PubMed ID: 397398
    [No Abstract]   [Full Text] [Related]  

  • 50. Prostacyclin overproduction in Bartter's syndrome.
    Stoff JS; MacIntyre DE; Brown RS; Salzman EW
    Lancet; 1979 Dec; 2(8153):1169-7. PubMed ID: 91898
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT; Aurecchia SA; Sindler BH; Melby JC
    J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of prostaglandin production of skin fibroblasts grown from patients with Bartter's syndrome and from age and sex matched controls.
    Müllner G; Gähwiler T; Lüthy C; Oetliker O; Dillon MJ; Rosa FC
    Prostaglandins Leukot Med; 1983 May; 11(1):83-93. PubMed ID: 6410415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostaglandins, potassium, and Bartter's syndrome.
    Ferris TF
    J Lab Clin Med; 1978 Nov; 92(5):663-8. PubMed ID: 361914
    [No Abstract]   [Full Text] [Related]  

  • 54. Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome.
    Rodriguez-Portales JA; Lopez-Moreno JM; Mahana D
    Hypertension; 1985; 7(6 Pt 1):1017-22. PubMed ID: 2416684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case with Bartter's syndrome associated with type II hyperlipidemia, increased fluidity of plasma VLDL and abnormal configuration of peripheral erythrocytes (author's transl)].
    Imai T; Makino K; Takeda N; Nakamura S; Endo Y; Okuyama M; Miura K; Iida H; Kawade M
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):131-47. PubMed ID: 7044842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bartter's syndrome: variability and clinical course].
    Cabezas R; Bosch F; García A; Ampudia J; Webb SM
    Med Clin (Barc); 1993 Jan; 100(2):63-5. PubMed ID: 8429712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of chloride transport in the thick ascending limb in the pathogenesis of Bartter's syndrome.
    Gill JR
    Klin Wochenschr; 1982 Oct; 60(19):1212-4. PubMed ID: 6755050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extra- and intracellular potassium concentration and prostaglandin production of skin fibroblasts grown from patients with Bartter's syndrome.
    Barth A; Fanzun C; Lüthy C; Siegrist M; Koegel R; Oetliker O
    Prostaglandins Leukot Med; 1986 Jan; 21(1):51-60. PubMed ID: 3081913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary kallikrein excretion in Bartter's syndrome.
    Lechi A; Covi G; Lechi C; Mantero F; Scuro LA
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1175-8. PubMed ID: 993321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chronization by indomethacin of the circadian rhythm of blood renin and aldosterone in a case of Bartter's syndrome].
    Cugini P; Lucia P; Murano G; Letizia C; Panichi G; Adone G; Vetere AM; Magnanelli S
    Minerva Urol Nefrol; 1985; 37(1):23-7. PubMed ID: 3901335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.